New Retina Radio
New Retina Radio

02.23.23

The Era of Geographic Atrophy Treatment Begins

The FDA approval of pegcetacoplan (Syfovre, Apellis Pharmaceuticals) is a historic moment for the field of retina, finally providing a treatment option for patients with geographic atrophy. Allen C. Ho, MD, and Robert L. Avery, MD, share their initial reactions to the approval and discuss the potential effect on patient care and clinical practice. 

View full description +

MORE EPISODES

10.10.25

New Retina Radio Journal Club w/ VBS: Time-Driven Cost Analysis of PRP: Dollars, Minutes, and Patient Care

Niki Kothari, MD; Jesse Sengillo, MD; and Nicholas Farber, MD

10.09.25

The Nuts and Bolts of GA Therapy: The Opening Sessions

Charles Wykoff, MD, PhD; with Maryam Ghiassi, MD, MHS, and Matthew Cunningham, MD

10.02.25

Keeping Patients at the Center of GA Therapy: Preserving Vision vs Restoring Vision

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

10.02.25

Keeping Patients at the Center of GA Therapy: Dosing Schedules, AREDS Vitamins, and Photobiomodulation

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

10.02.25

Keeping Patients at the Center of GA Therapy: Patient Education and Setting Expectations

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

10.02.25

Keeping Patients at the Center of GA Therapy: Social Impact and Early Intervention

John Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD

09.26.25

New Retina Radio Journal Club w/ VBS: Aflibercept 8 mg in nAMD: Outcomes After Switching From Faricimab

09.04.25

ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDR

David Lally, MD; and Ehsan Rahimy, MD

Show More